HSCs-derived exosomes regulate the levels of inflammatory cytokines in HIBECs through miR-122-5p mediated p38 MAPK signaling pathway

• Published in: Genomics (San Diego, Calif.) Calif.), 2024-03, Vol.116 (2), p.110795, Article 110795
• Main Authors: Zhang, Yaqin, Zhang, Xiangzhi, Chen, Ruofei, Jiao, Ziying, Shen, Bing, Shuai, Zongwen
• Format: Article
• Language: English
• Subjects: Exosomes; Intrahepatic biliary epithelial cells; miR-122-5p; Primary biliary cholangitis
• ISSN: 0888-7543; 1089-8646; 1089-8646
• DOI: 10.1016/j.ygeno.2024.110795

PBC is an autoimmune-mediated liver disease, and intrahepatic biliary epithelial cells (IBECs) are the target cells of early damage. Previous studies found that miRNAs and inflammation is closely related to PBC. In this study, we extracted exosomes from serum and human IBECs supernatant, and RNA-sequence analyzed the expression profiles of miRNAs. Elisa measured the levels of inflammatory cytokines. RT- qPCR and western blot detected the levels of miR-122-5p, p38 and p-p38. The results showed that 263 differentially expressed (DE) miRNAs were identified in serum exosomes of PBC patients. The levels of IL-1β, IL-6, IL-12, IL-17 A, IFN-γ, TNF-α and TGF-β1 in peripheral blood of PBC patients were higher than those of normal controls. According to the validation results and previous literature, exosomal miR-122-5p was finally selected as the study object, and correlated with inflammatory factors. In vitro experiments further found that exosomal miR-122-5p may derive from hepatic stellate cells (HSCs), and can be HIBECs intake, and influence HIBECs inflammatory factor levels though p38 MAPK signaling pathways. This may provide a new strategy for the treatment of PBC. •We comprehensively analyzed the expression profile of serum exosomal miRNAs in PBC patients for the first time.•To find the association between exosomal miR-122-5p and inflammatory factors for the first time,•This may provide a new strategy for the treatment of PBC.